Abstract:Complement activation through antibody-antigen complexes is crucial in various pathophysiological processes such as infections, inflammation, and autoimmunity, but is also utilized in immunotherapies to eliminate infectious agents, regulatory immune cells, or cancer cells. Although the tertiary structures of the four IgG antibody subclasses are largely identical, complement recruitment and further activation depend strongly on subclass, which is commonly explained by the respective affinity for C1, the first component of the classical complement pathway. Contradicting this established view, we here demonstrate that complement activation by different IgG subclasses is determined by their varying ability to form IgG oligomers on antigenic surfaces large enough to multivalently bind and activate C1. We directly visualize the resulting IgG oligomer structures and characterize their distribution by means of high-speed atomic force microscopy (HS-AFM), quantify their complement recruitment efficiency from quartz crystal microbalance (QCM) experiments, and characterize their ability to activate complement on tumor cell lines as well as in vesicle-based complement lysis assays. We present a mechanistic model of the multivalent interactions that govern C1 binding to IgG oligomers and use this model to extract affinities and kinetic rate constants from real-time interaction QCM data. Together, our detailed characterization yields a comprehensive view on the parameters that govern complement activation by the different IgG subclasses, which may inform the design of future antibody therapies.

What problem does this paper attempt to address?

The paper attempts to address the issue of the ability and mechanism of different IgG subclasses to activate the complement system. Specifically, the authors studied the ability of different IgG subclasses (IgG1, IgG2, IgG3, and IgG4) to form oligomers after binding to antigens and explored how this ability affects the activation of the complement system. The main objectives include: 1. **Explaining IgG subclass differences**: The traditional view is that the differences in the ability of different IgG subclasses to activate the complement system are mainly due to their different affinities for the complement component C1q. However, the authors of this paper found through experiments that complement activation actually depends on the ability of IgG to form oligomers on the antigen surface. 2. **Validating the importance of oligomerization**: Using high-resolution atomic force microscopy (HS-AFM), the oligomer structures of different IgG subclasses on lipid bilayers were observed and their distribution quantified. The results showed that only sufficiently large oligomers can effectively activate the complement system. 3. **Assessing the impact of point mutations**: The study examined the effect of the E430G point mutation on different IgG subclasses. The results showed that this mutation can significantly enhance the oligomerization ability and complement-dependent cytotoxicity (CDC) of IgG2 and IgG4, but has a smaller effect on IgG3. 4. **Determining the relationship between oligomerization and complement recruitment**: Through quartz crystal microbalance (QCM) experiments, the efficiency of complement C1 recruitment by different IgG subclasses and their mutants at different antigen densities was studied. The results indicated that the higher the degree of oligomerization, the more efficient the complement recruitment. 5. **Revealing kinetic mechanisms**: By constructing a kinetic model, the interaction between C1/C1q and IgG oligomers was analyzed, and the relevant kinetic parameters were extracted. The results found that the binding affinity of individual IgG within the oligomer to C1q is higher than that of monomeric IgG. In summary, this paper aims to reveal the critical role of IgG oligomerization in complement activation through comprehensive research and to provide a theoretical basis for the design of future antibody therapies.

Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding

Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces.

Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Molecular Recognition of Fc-Specific Ligands Binding Onto the Consensus Binding Site of Igg: Insights from Molecular Simulation

Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen

Factors affecting IgG4-mediated complement activation

Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics

The Fc fragment of soluble IgMs binds C1q to activate the classical complement pathway, while inhibiting complement-dependent cytotoxicity

The Ligands for Human IgG and Their Effector Functions

Antibody density on bacteria regulates C1q recruitment by monoclonal IgG but not IgM

The structural requirements for complement activation by IgG: does it hinge on the hinge?

Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen

The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals

3D Structures of IgA, IgM, and Components

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities

Antigen Induced Dynamic Conformation Changes of Antibody to Facilitate Recognition of Fc Receptors

Regulation of humoral immunity by complement

Biophysical Characterization and Stability of Modified IgG1 Antibodies with Different Hexamerization Propensities.

Structural Insights into Immunoglobulin M

The Solvent at Antigen-Binding Site Regulated C3d-CR2 Interactions Through the C-terminal Tail of C3d at Different Ion Strengths: Insights from Molecular Dynamics Simulation.

Antigen Binding Allosterically Promotes Fc Receptor Recognition.